Intra-Patient Heterogeneity of Circulating Tumor Cells and Circulating Tumor DNA in Blood of Melanoma Patients

Despite remarkable progress in melanoma therapy, the exceptional heterogeneity of the disease has prevented the development of reliable companion biomarkers for the prediction or monitoring of therapy responses. Here, we show that difficulties in detecting blood-based markers, like circulating tumor...

Descripción completa

Detalles Bibliográficos
Autores principales: Gorges, Katharina, Wiltfang, Lisa, Gorges, Tobias M., Sartori, Alexander, Hildebrandt, Lina, Keller, Laura, Volkmer, Beate, Peine, Sven, Babayan, Anna, Moll, Ingrid, Schneider, Stefan W., Twarock, Sören, Mohr, Peter, Fischer, Jens W., Pantel, Klaus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896052/
https://www.ncbi.nlm.nih.gov/pubmed/31671846
http://dx.doi.org/10.3390/cancers11111685

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896052/
https://www.ncbi.nlm.nih.gov/pubmed/31671846
http://dx.doi.org/10.3390/cancers11111685

Ejemplares similares